Drug Type Small molecule drug |
Synonyms- |
Target |
Action antagonists |
Mechanism AR antagonists(Androgen Receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H15N3O3S |
InChIKeyWHMHGXSWQAALSF-UHFFFAOYSA-N |
CAS Registry1240219-39-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Preclinical | China | 30 Nov 2018 |